Phyton Biotech (Germany/US)
EMEA
Ahrensburg
,
Germany
Established
FOUNDED
1990
HEADCOUNT
FUNDING
Subsidiary
Keywords:
fermentation, bioreactor_design, therapeutics, CDMO
BUSINESS
Phyton Biotech is a CDMO and the world's largest producer of paclitaxel and docetaxel, using proprietary Plant Cell Fermentation (PCF) technology. It manufactures plant-derived molecules, extracts and recombinant products for pharmaceutical, cosmetic, agricultural and food markets. Founded in 1990 (Ithaca, NY) and acquired by DFB Pharmaceuticals in 2003, it operates facilities in Ahrensburg, Germany and Delta, Canada.
BIOTECH INVOLVEMENT
Core; produces paclitaxel and other taxanes via proprietary plant cell fermentation (PCF) in stirred-tank bioreactors (>200,000 L capacity).
TECHNOLOGY PLATFORM
Plant Cell Fermentation (PCF) in stirred-tank bioreactors
PRIMARY PRODUCTS
paclitaxel; docetaxel; other taxanes/plant-cell-derived molecules